What Problems Do Preterm Babies Have With Surfactant Surfactant

Log in to MyKarger to check if y'all already have access to this content.

Purchase

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal utilize

read more


CHF 38.00 *
EUR 35.00 *
USD 39.00 *


Select

KAB

Buy a Karger Article Bundle (KAB) and turn a profit from a disbelieve!

If you would like to redeem your KAB credit, delight log in.


Save over 20% compared to the individual article price.


Acquire more

Rent/Deject

  • Rent for 48h to view
  • Buy Deject Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Press and saving restrictions apply

Rental: USD 8.l
Cloud: USD twenty.00


Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-admission via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use

read more


Subcription rates


Select

* The final prices may differ from the prices shown due to specifics of VAT rules.


Article / Publication Details

Get-go-Page Preview

Abstract of Original Paper

Received: March 24, 2016
Accepted: September 24, 2016
Published online: January eleven, 2017
Issue release date: May 2017

Number of Print Pages: half-dozen
Number of Figures: ii
Number of Tables: 2

ISSN: 1661-7800 (Print)
eISSN: 1661-7819 (Online)

For additional information: https://www.karger.com/NEO

Abstruse

Background: In recent years, early nasal continuous positive airway force per unit area (nCPAP) every bit respiratory support for preterm infants is being advocated equally an culling to prophylactic surfactant and handling with mechanical ventilation. A number of infants treated with early nCPAP do not need treatment with surfactant, but few studies provide information on this. Since the 1990s, the kickoff arroyo to respiratory support to preterm infants in Denmark has been early nCPAP combined with surfactant administration by the INSURE method by which the infant is intubated and surfactant administration is followed by rapid extubation to nCPAP if possible. Objectives: To investigate how oft surfactant was administered in preterm infants with a gestational historic period below 34 weeks treated with early nCPAP equally a first approach to respiratory support. Methods: An observational multicentre study including all inborn infants with a gestational historic period below 34 weeks admitted to one of the 4 level 3 neonatal intensive care units in Denmark in the period from 2000 to 2013. Results: A total of half dozen,628 infants were included in this report. We constitute that surfactant was administered in 1,056 of 1,799 (59%; 95% CI: 57-61%), in 821 of 2,864 (29%; 95% CI: 27-31%), and in 132 of 1,796 (vii%; 95% CI: 6-8%) of the infants with a gestational age from 24 to 27, 28 to 31, and 32 to 33 weeks and six days, respectively. Conclusions: A large proportion of preterm infants treated with early on nCPAP as the showtime approach to respiratory support was never treated with surfactant.

© 2017 South. Karger AG, Basel


References

  1. St Clair C, Norwitz ER, Woensdregt K, Cackovic One thousand, Shaw JA, Malkus H, Ehrenkranz RA, Illuzzi JL: The probability of neonatal respiratory distress syndrome as a function of gestational age and lecithin/sphingomyelin ratio. Am J Perinatol 2008;25:473-480.
  2. Dani C, Reali MF, Bertini Thou, Wiechmann 50, Spagnolo A, Tangucci M, Rubaltelli FF: Risk factors for the development of respiratory distress syndrome and transient tachypnoea in newborn infants. Italian Group of Neonatal Pneumology. Eur Respir J 1999;14:155-159.
  3. Hobel CJ, Hyvarinen MA, Oh Due west: Abnormal fetal heart charge per unit patterns and fetal acid-base balance in low nascence weight infants in relation to respiratory distress syndrome. Obstet Gynecol 1972;39:83-88.
  4. Nagourney BA, Kramer MS, Klebanoff MA, Usher RH: Recurrent respiratory distress syndrome in successive preterm pregnancies. J Pediatr 1996;129:591-596.
  5. Liggins GC, Howie RN: A controlled trial of antepartum glucocorticoid handling for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972;50:515-525.
  6. Fujiwara T, Maeta H, Chida Due south, Morita T, Watabe Y, Abe T: Bogus surfactant therapy in hyaline-membrane disease. Lancet 1980;1:55-59.
  7. Jacobsen T, Grønvall J, Petersen S, Andersen GE: "Minitouch" treatment of very low-birth-weight infants. Acta Paediatr 1993;82:934-938.
  8. Verder H, Robertson B, Greisen G, Ebbesen F, Albertsen P, Lundstrøm K, Jacobsen T: Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish-Swedish Multicenter Report Group. N Engl J Med 1994;331:1051-1055.
  9. Verder H, Albertsen P, Ebbesen F, Greisen G, Robertson B, Bertelsen A, Agertoft L, Djernes B, Nathan E, Reinholdt J: Nasal continuous positive airway force per unit area and early surfactant therapy for respiratory distress syndrome in newborns of less than thirty weeks' gestation. Pediatrics 1999;103:E24.
  10. Sweet D, Carnielli V, Greisen G, Hallman K, Ozek East, Plavka R, Saugstad OD, Simeoni U, Speer CP, Halliday H; European Association of Perinatal Medicine: European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants - 2013 update. Neonatology 2013;103:353-368.
  11. Andersson S, Petersen JP, Henriksen TB, Ebbesen F: The Danish neonatal clinical database is valuable for epidemiologic research in respiratory disease in preterm infants. BMC Pediatr 2014;14:47.
  12. Lando A, Kure Østergaard K, Greisen G: Comparing minimally invasive and proactive initial management of extremely preterm infants. Acta Paediatr 2014;103:827-832.
  13. The Danish National Nascency Register. http://sundhedsdatastyrelsen.dk/da/registre-og-services/om-de-nationale-sundhedsregistre/graviditet-foedsler-og-boern/foedselsregisteret.
  14. Hansen BM, Hoff B, Greisen G, Mortensen EL: Early nasal continuous positive airway pressure level in a accomplice of the smallest infants in Denmark: neurodevelopmental issue at five years of age. Acta Paediatr 2004;93:190-195.
  15. Finer NN, Carlo WA, Walsh MC, Rich Due west, Gantz MG, Laptook AR, Yoder BA, Faix RG, Das A, Poole WK, Donovan EF, Newman NS, Ambalavanan N, Frantz ID third, Buchter S, Sánchez PJ, Kennedy KA, Laroia N, Poindexter BB, Cotten CM, Van Meurs KP, Duara S, Narendran 5, Sood BG, O'Shea TM, Bell EF, Bhandari V, Watterberg KL, Higgins RD: Early CPAP versus surfactant in extremely preterm infants. Northward Engl J Med 2010;362:1970-1979.
  16. Dunn MS, Kaempf J, de Klerk A, de Klerk R, Reilly M, Howard D, Ferrelli K, O'Conor J, Soll RF: Randomized trial comparing iii approaches to the initial respiratory management of preterm neonates. Pediatrics 2011;128:e1069-e1076.
  17. Göpel W, Kribs A, Ziegler A, Laux R, Hoehn T, Wieg C, Siegel J, Avenarius S, von der Wense A, Vochem Yard, Groneck P, Weller U, Möller J, Härtel C, Haller South, Roth B, Herting E: Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial. Lancet 2011;378:1627-1634.

Commodity / Publication Details

Commencement-Page Preview

Abstract of Original Paper

Received: March 24, 2016
Accepted: September 24, 2016
Published online: January xi, 2017
Issue release date: May 2017

Number of Print Pages: vi
Number of Figures: 2
Number of Tables: 2

ISSN: 1661-7800 (Print)
eISSN: 1661-7819 (Online)

For additional data: https://world wide web.karger.com/NEO

williamsforivento95.blogspot.com

Source: https://www.karger.com/Article/Fulltext/451021

0 Response to "What Problems Do Preterm Babies Have With Surfactant Surfactant"

Post a Comment

Iklan Atas Artikel

Iklan Tengah Artikel 1

Iklan Tengah Artikel 2

Iklan Bawah Artikel